We are live on
!
Find out more
Acadian Asset Management Portfolio holdings
AUM
$70.5B
1-Year Est. Return
36%
This Fund
S&P 500
This Quarter
Est. Return
+7.95%
1 Year Est. Return
+36%
3 Year Est. Return
+137.96%
5 Year Est. Return
+215.76%
10 Year Est. Return
+864.44%
AUM
$24.3B
AUM Growth
+$1.52B
(+6.7%)
Cap. Flow
+$416M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
19.48%
Holding
1,977
New
232
Increased
535
Reduced
722
Closed
249
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$298M |
| 2 |
Spotify
SPOT
|
+$249M |
| 3 |
NVIDIA
NVDA
|
+$230M |
| 4 |
Cardinal Health
CAH
|
+$129M |
| 5 |
Vipshop
VIPS
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amdocs
DOX
|
+$125M |
| 2 |
Crane NXT
CXT
|
+$114M |
| 3 |
Deutsche Bank
DB
|
+$96M |
| 4 |
Qiagen
QGEN
|
+$92.3M |
| 5 |
Arista Networks
ANET
|
+$83.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.06% |
| 2 | Healthcare | 13.93% |
| 3 | Consumer Staples | 11.94% |
| 4 | Consumer Discretionary | 10.19% |
| 5 | Communication Services | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Lowe's Companies
LOW
$123B
| $3.1M | 0.01% |
13,737
-1,956
| -12% | -$407K |
|
577
Idexx Laboratories
IDXX
$46.9B
| $3.09M | 0.01% |
6,166
-672
| -10% | -$322K |
|
578
UiPath
PATH
$8.08B
| $3.09M | 0.01% |
186,677
+4,322
| +2% | +$69.3K |
|
579
Varonis Systems
VRNS
$4.87B
| $3.08M | 0.01% |
115,671
+30,349
| +36% | +$758K |
|
580
eHealth
EHTH
$40.4M
| $3.08M | 0.01% |
383,116
+220,566
| +136% | +$1.76M |
|
581
Emerson Electric
EMR
$88.5B
| $3.08M | 0.01% |
34,073
+33,195
| +3,781% | +$2.79M |
|
582
Anika Therapeutics
ANIK
$277M
| $3.07M | 0.01% |
118,143
-55,003
| -32% | -$1.47M |
|
583
Edwards Lifesciences
EW
$53B
| $3.04M | 0.01% |
32,294
-26,055
| -45% | -$2.26M |
|
584
Sutro Biopharma
STRO
$423M
| $3.04M | 0.01% |
65,447
-3,277
| -5% | -$163K |
|
585
KB Financial Group
KB
$42.4B
| $3.02M | 0.01% |
83,121
-18,158
| -18% | -$670K |
|
|
TBRG
586
DELISTED
TruBridge
TBRG
| $3.02M | 0.01% |
122,374
-60,658
| -33% | -$1.58M |
|
587
Relmada Therapeutics
RLMD
$484M
| $3M | 0.01% |
1,221,399
| – | – |
|
|
TAST
588
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $2.99M | 0.01% |
593,638
+409,718
| +223% | +$1.86M |
|
589
CareDx
CDNA
$2.44B
| $2.99M | 0.01% |
+351,456
| New | +$2.93M |
|
590
Cellebrite
CLBT
$3.97B
| $2.98M | 0.01% |
416,236
+294,778
| +243% | +$1.72M |
|
591
Iron Mountain
IRM
$36.2B
| $2.98M | 0.01% |
52,585
+43,618
| +486% | +$2.39M |
|
592
Essential Utilities
WTRG
$11.3B
| $2.98M | 0.01% |
74,804
| – | – |
|
593
Kamada
KMDA
$412M
| $2.97M | 0.01% |
566,239
-79,478
| -12% | -$392K |
|
594
Northeast Community Bancorp
NECB
$364M
| $2.97M | 0.01% |
199,803
-39,910
| -17% | -$538K |
|
595
Prudential Financial
PRU
$42.1B
| $2.97M | 0.01% |
33,652
-107,020
| -76% | -$8.95M |
|
596
GeoPark
GPRK
$627M
| $2.96M | 0.01% |
298,552
-44,446
| -13% | -$468K |
|
597
American Express
AXP
$229B
| $2.95M | 0.01% |
16,961
-3,304
| -16% | -$533K |
|
|
NGM
598
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $2.95M | 0.01% |
1,138,843
+200,409
| +21% | +$715K |
|
599
Westlake Corp
WLK
$10.1B
| $2.93M | 0.01% |
24,553
-212
| -0.9% | -$24.3K |
|
600
OP Bancorp
OPBK
$233M
| $2.92M | 0.01% |
346,282
-1,864
| -0.5% | -$15.8K |
|
Similar funds
Acadian Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Acadian Asset Management held 1,977 positions worth $24.3B, up 6.7% from $22.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Acadian Asset Management's Q2 2023 filing shows 232 new, 535 increased, 722 reduced and 249 closed positions. Its largest new stake was Indivior Pharmaceuticals: 2,328,706 shares worth $54M. The largest sale was Amdocs, an estimated $125M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Staples.
- Acadian Asset Management's largest Q2 2023 buy was Indivior Pharmaceuticals: 2,328,706 shares worth $54M.
- Acadian Asset Management added most to Alphabet (Google) Class A in Q2 2023, an estimated $298M increase.
- Acadian Asset Management's biggest Q2 2023 reduction was Crane NXT, cutting an estimated $114M.
- Acadian Asset Management fully exited Amdocs in Q2 2023, selling an estimated $125M.
- Acadian Asset Management's ten largest holdings make up 19% of its $24.3B portfolio in Q2 2023.
- Acadian Asset Management opened 232 new positions and closed 249 in Q2 2023.
- Acadian Asset Management's portfolio value rose 6.7% quarter-over-quarter to $24.3B.
Based on Acadian Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.